About The Study:

Influenza virus strains change, which is why flu vaccines are often updated. mRNA vaccine technology is being used in the development of vaccines. At RCR, we are currently conducting a study that is testing a new mRNA multivalent flu vaccine. Flu vaccines each have to go through the same kinds of studies to get FDA approval. During any clinical trial, the safety of participants is of the utmost importance and the consent process is how we make sure that participants understand the risks and benefits of participation.

We are looking for participants who are 18 years or older to participate. Everyone participating will get a flu vaccine, and the study could last about 6 months, including up to 5 visits to our office. Study-related care is available to participants at no cost and health insurance is not required nor needed.


  • Must be 18 years or older to participate
  • Have not received a flu shot in the last 6 months
  • Generally healthy (stable chronic conditions)
  • *Please note, other conditions apply